Additional file 3 of Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial

Authors :: De Leeuw, Elisabeth
Van Damme, Karel F. A.
Declercq, Jozefien
Bosteels, Cedric
Maes, Bastiaan
Tavernier, Simon J.
Detalle, Laurent
Smart, Trevor
Glatt, Sophie
Debeuf, Nincy
Deckers, Julie
Lameire, Sahine
Vandecasteele, Stefaan J.
De Neve, Nikolaas
Demedts, Ingel K.
Govaerts, Elke
Knoop, Christiane
Vanhove, Karolien
Moutschen, Michel
Terryn, Wim
Depuydt, Pieter
Van Braeckel, Eva
Haerynck, Filomeen
Hendrickx, Tine C. J.
Parrein, Vanessa
Lalla, Marianna
Brittain, Claire
Lambrecht, Bart N.
Publication Year :: 2022
Publisher :: figshare, 2022.
Abstract: Additional file 3. Overview secondary and exploratory endpoints.

Full Text Access

Tools